0001485003-16-000168.txt : 20160922
0001485003-16-000168.hdr.sgml : 20160922
20160922164529
ACCESSION NUMBER: 0001485003-16-000168
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160920
FILED AS OF DATE: 20160922
DATE AS OF CHANGE: 20160922
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 252025616
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-9911
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Celniker Abbie
CENTRAL INDEX KEY: 0001590250
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 161897999
MAIL ADDRESS:
STREET 1: C/O ELEVEN BIOTHERAPEUTICS, INC.
STREET 2: 215 FIRST STREET, SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
wf-form4_147457710338447.xml
FORM 4
X0306
4
2016-09-20
0
0001485003
Eleven Biotherapeutics, Inc.
EBIO
0001590250
Celniker Abbie
C/O ELEVEN BIOTHERAPEUTICS, INC.,
215 FIRST STREET, SUITE 400
CAMBRIDGE
MA
02142
1
0
0
0
Stock Option (Right to Buy)
0.28
2016-09-20
4
A
0
29988
0
A
2016-09-20
2026-02-24
Common Stock
29988.0
90000
D
On February 25, 2016, the reporting person was granted an option to purchase 90,000 shares of common stock. This option vests in installments based on the achievement of certain regulatory and business milestones. The Compensation Committee of the Company determined that one of these performance milestones was met, resulting in vesting of the option with respect to 29,988 shares. The option had previously vested with respect to 60,012 shares.
/s/ John J. McCabe as attorney-in-fact
2016-09-22